Abstract:P1009 Purpose: We have previously demonstrated that targeting both dendritic cells and T cells simultaneously achieved reliable tolerance in a mouse transplant model, which depended on a regulatory feedback loop (J Immunol 2003, 170:1304) between tolerogenic dendritic cells (Tol-DC) and T regulatory cells (Treg). The present study was undertaken to determine if there is synergy in the induction of tolerance by simultaneous adoptive transfer of Tol-DC and Treg. Methods: BALB/c mice receiving C57BL/6 cardiac allografts were treated with LF 15-0195, a novel analogue of 15-deoxysperqualine at dose of 2 mg/kg for 20 days and long-term survivors (>100 days) were defined as tolerant recipients. CD11c+ dendritic cells, CD4+CD25+ and CD8+CD28- Treg cells were isolated from spleens of tolerant recipients. Tol-DC alone (5x106/mouse), Treg alone (1x106/mouse) or a combination of Tol-DC and Treg were intravenously injected into naive BALB/c recipients prior to and/or after allogeneic (C57/BL6->Balb/c) transplantation. The recipients received sublethal radiation and no additional immunosuppressants were used. Results: The Tol-DC isolated from tolerant recipients demonstrated immature phenotypes, impaired antigen presenting function, and inhibited allostimulatory capacity. Adoptive transfer of Tol-DC significantly prolonged allograft survival to a median survival time (MST) of 38 days, while recipients without transfer survived to MST of 13 days. On the other hand, CD4+CD25+ and CD8+CD28- T cell subsets were significantly increased in tolerant recipients as compared with rejecting recipients and non-transplanted mice. Both ex vivo isolated CD4+CD25+ and CD8+CD28- T cells potently suppressed ongoing MLR in vitro, suggesting they possess Treg function. Furthermore, both Treg subsets synergized with Tol-DC in the induction of tolerance. Adoptive transfer of a combination of Tol-DC and a subtherapeutic dose of either CD4+CD25+ or CD8+CD28- Treg significantly prolonged survival to MST of 85 days (P<0.05) and MST of 105 days (P<0.01), respectively. Conclusions: This study provides the first direct evidence that Tol-DC synergize with Treg in the induction of transplant tolerance. These findings shed light on mechanisms of tolerance induction through the regulatory feedback loop between Tol-DC and Treg.

Tipping the balance toward transplantation tolerance: in vivo therapy using a mutated IL-2

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models

In Vivo Environment Necessary to Support Transplanted Donor Mouse T Regulatory Cells

Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance

Guiding Postablative Lymphocyte Reconstitution as a Route Toward Transplantation Tolerance

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

T regulatory cells as an immunotherapy for transplantation.

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

T Regulatory Cells As an Immunotherapy for Transplantation

Regulating Regulatory T Cells to Achieve Transplant Tolerance.

Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases

Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance

New Insights on T Cell Apoptosis in the Induction of Treg-Dependent Dominant Tolerance

CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance.

Regulatory T cells and transplantation tolerance.

SYNERGISTIC TOLERANCE BY ADOPTIVE TRANSFER OF TOLEROGENIC DENDRITIC CELLS AND T REGULATORY CELLS:

IL-2 synergy CD45RB mAbs regulate the ratio of Treg/Th17 cells and prolong the survival times of the skin allografts in mice

Regulatory-B Cell and Regulatory-T Cell Collaborate to Promote Transplantation Tolerance (126.2)

Low-Dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?

Tregs in transplantation tolerance: role and therapeutic potential